Clinical Trial Search

Primary: Number of Cases of ABU That Are Treated Inappropriately With Antibiotics — 1.6; 0.6; 0.5; 0.6 cases/1,000 bed-days

Primary: The Number of Patients Receiving Appropriate Treatment — 44; 29 Participants

Primary: Proportion of Asymptomatic Bacteriuria Treated With Antibiotics and Urinary Tract Infection Treated With Antibiotics — 31; 25 Participants

Primary: Number of Participants Who Have Cystitis — 4; 4 Participants

Primary: Antimicrobial Activity of Urine From Pregnant Subjects Following Cranberry Juice Cocktail (CJC) — 117.5; 105.0; 110.0 cfu per ml

Primary: Number of Participants With Bacterial Vaginosis Recurrence — 8 Participants

Primary: False Positive Urine — 6; 40 Participants

Primary: Bacterial Genomic Sequencing — 25; 11; 3; 6 participants

Primary: Total Bacteria Count Change From Baseline and After 24 Hours. — -62519; 57448 CFU/mL — p=0.6250

Primary: Rate of UTI While Colonized With E. Coli 83972. — 8.5 UTIs per 1000 patient-days

Primary: Number of Participants Experiencing Urinary Tract Infection Within 6 Weeks of Surgery — 13; 13 Participants — p=0.97

Primary: Urinary Tract Infections — 18; 10 participants

Primary: Participants With Urine Cultures With Bacteriuria (>100,000 Cfu/ml or >=100,000 Cfu/ml) Plus Pyuria (Any WBC) — 26; 32; 21; 27 participants

Primary: Changes to the Urinary Microbiota — 3; 2; 1 participants

Primary: Post-operative Urinary Tract Infection — 19; 20 Participants

Primary: Percentage of Microbiologic Modified Intent to Treat Resistant (Micro-MITTR) Participants With Overall Success — 62.6; 36.0 percentage of participants

Primary: To Evaluate the Effect of Oral Supplementation With Lactobacillus Reuteri on the Frequency of Confirmed UTI in Adult Women With Recurrent UTI. — 1.2; 1.3 Number of…

Primary: Measures of Liver Function: AST and ALT — 36.2; 52; 31.7; 57.86 IU/L

Primary: Number of Participants With a Catheter Associated Urinary Tract Infection (CAUTI) — 7; 6 Participants

Primary: Treatment of Clinically Suspected UTI - Using Intent to Treat Analysis — 13; 12 Participants

Primary: Number of Subjects With Combined Clinical and Microbiologic Response — 70 Participants

Primary: Bladder Colonization — 62 percentage of participants

Primary: Percentage of Participants Achieving Clinical Symptom Improvement at 24 Hours (±4 Hours) — 54.4 Percentage of participants

Primary: Incidence of Urinary Tract Infection — 7; 13 participants

Primary: Urinary Tract Infection — 11; 12 UTI

Primary: Number of Participants With Appropriate Treatment — 31; 23 Participants — p=0.45

Primary: Proportion of Patients Who Achieve Composite Clinical and Microbiological Success at TOC (Test of Cure Visit) in the Microbiological Modified Intent-to-Treat (m-MITT)…

Primary: Eligible Subjects That Were Enrolled in the Study — 70 Participants

Primary: Number of Participants With Treatment-related Adverse Events as Assessed by DAIDS v2.1 — 0; 0 Participants

Primary: UTI — 15; 14 Participants — p=0.84